Monoamine neurotransmitters and fibroblast growth factor-2 in the brains of rats with post-stroke depression

Experimental and Therapeutic Medicine

Volumn 8, Issue 1, 2014, Pages 159-164

  Ji, Xiao Wei ^a   Wu, Chun Ling ^b   Wang, Xing Chen ^a   Liu, Jie ^a   Bi, Jian Zhong ^a   Wang, Dian Yun ^c  

^a THE SECOND HOSPITAL OF SHANDONG UNIVERSITY   (China)

^b JINAN CENTRAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^c DONGYING PEOPLE S HOSPITAL   (China)

Author keywords

Dopamine; Fibroblast growth factor 2; Norepinepherine; Post stroke depression rat; Serotonin

Indexed keywords

DOPAMINE; FIBROBLAST GROWTH FACTOR 2; MESSENGER RNA; MONOAMINE; NEUROTRANSMITTER; NORADRENALIN; SEROTONIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DEPRESSION; FRONTAL LOBE; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

EID: 84901350016     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2014.1674     Document Type: Article

References (45)

1. Yang LL, Zhang ZJ and Sun DM: Incidence and its risk factors of post-stroke depression in cerebral stroke patients at acute stage. Lin Chuang Shen Jing Bing Xue Za Zhi 23: 185-187, 2010 (In Chinese).
2. Berg C, Backström T, Winberg S, et al: Developmental exposure to fluoxetine modulates the serotonin system in hypothalamus. PLoS One 8: e55053, 2013.
3. Sullivan GM, Ogden RT, Huang YY, et al: Higher in vivo serotonin-1a binding in posttraumatic stress disorder: a PET study with [11C]WAY-100635. Depress Anxiety 30: 197-206, 2013.
4. Spasojevic N, Jovanovic P and Dronjak S: Chronic fluoxetine treatment affects gene expression of catecholamine enzymes in the heart of depression model rats. Indian J Exp Biol 50: 771-775, 2012.
5. Vergaño-Vera E, Méndez-Gómez HR, Hurtado-Chong A, et al: Fibroblast growth factor-2 increases the expression of neurogenic genes and promotes the migration and differentiation of neurons derived from transplanted neural stem/progenitor cells. Neuroscience 162: 39-54, 2009.
6. Reynolds BA and Weiss S: Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 255: 1707-1710, 1992.
7. Vicario-Abejón C, Yusta-Boyo MJ, Fernández-Moreno C and de Pablo F: Locally born olfactory bulb stem cells proliferate in response to insulin-related factors and require endogenous insulin-like growth factor-I for differentiation into neurons and glia. J Neurosci 23: 895-906, 2003.
8. Gritti A, Parati EA, Cova L, Frolichsthal P, et al: Multipotential stem cells from the adult mouse brain proliferate and self-renew in response to basic fibroblast growth factor. J Neurosci 16: 1091-1100, 1996.
9. Turner CA, Watson SJ and Akil H: The fibroblast growth factor family: neuromodulation of affective behavior. Neuron 76: 160-174, 2012.
10. Fukuchi-Shimogori T and Grove EA: Neocortex patterning by the secreted signaling molecule FGF 8. Science 294: 1071-1074, 2001.
11. Shin DM, Korada S, Raballo R, et al: Loss of glutamatergic pyramidal neurons in frontal and temporal cortex resulting from attenuation of FGFR1 signaling is associated with spontaneous hyperactivity in mice. J Neurosci 24: 2247-2258, 2004.
12. Guillemot F and Zimmer C: From cradle to grave: the multiple roles of fibroblast growth factors in neural development. Neuron 71: 574-588, 2011.
13. Vaccarino FM, Schwartz ML, Raballo R, et al: Changes in cerebral cortex size are governed by fibroblast growth factor during embryogenesis. Nat Neurosci 2: 246-253, 1999.
14. Raballo R, Rhee J, Lyn-Cook R, et al: Basic fibroblast growth factor (Fgf2) is necessary for cell proliferation and neurogenesis in the developing cerebral cortex. J Neurosci 20: 5012-5023.
15. Mason I: Initiation to end point: the multiple roles of fibroblast growth factors in neural development. Nat Rev Neurosci 8: 583-596, 2007.
16. Ciccolini F and Svendsen CN: Fibroblast growth factor 2 (FGF-2) promotes acquisition of epidermal growth factor (EGF) responsiveness in mouse striatal precursor cells: identification of neural precursors responding to both EGF and FGF-2. J Neurosci 18: 7869-7880, 1998.
17. Ito Y, Tsurushima H, Sato M, et al: Angiogenesis therapy for brain infarction using a slow-releasing drug delivery system for fibroblast growth factor 2. Biochem Biophys Res Commun 432: 182-187, 2013.
18. Maric D, Fiorio Pla A, Chang YH and Barker JL: Self-renewing and differentiating properties of cortical neural stem cells are selectively regulated by basic fibroblast growth factor (FGF) signaling via specific FGF receptors. J Neurosci 27: 1836-1852, 2007.
19. Sun Y, Hu J, Zhou L, et al: Interplay between FGF2 and BMP controls the self-renewal, dormancy and differentiation of rat neural stem cells. J Cell Sci 124: 1867-1877, 2011.
20. Vicario-Abejón C, Johe KK, Hazel TG, et al: Functions of basic fibroblast growth factor and neurotrophins in the differentiation of hippocampal neurons. Neuron 15: 105-114, 1995.
21. Cattaneo E and McKay R: Proliferation and differentiation of neuronal stem cells regulated by nerve growth factor. Nature 347: 762-765, 1990.
22. Gillen R, Tennen H, McKee TE, et al: Depressive symptoms and history of depression predict rehabilitation efficiency in stroke patients. Arch Phys Med Rehabil 82: 1645-1649, 2001.
23. Singh A, Black SE, Herrmann N, et al: Functional and neuroanatomic correlations in poststroke depression: the Sunnybrook Stroke Study. Stroke 31: 637-644, 2000.
24. Vataja R, Pohjasvaara T, Mäntylä R, et al: Depression-executive dysfunction syndrome in stroke patients. Am J Geriatr Psychiatry 13: 99-107, 2005.
25. Kishi Y, Kosier T and Robinson RG: Suicidal plans in patients with acute stroke. J Nerv Ment Dis 184: 274-280, 1996.
26. House A, Knapp E, Bamford J and Vail A: Mortality at 12 and 24 months after stroke may be associated with depressive symptoms at 1 month. Stroke 32: 696-701, 2001.
27. Everson SA, Roberts RE, Goldberg DE and Kaplan GA: Depressive symptoms and increased risk of stroke mortality over a 29-year period. Arch Intern Med 158: 1133-1138, 1998.
28. Robinson RG, Bolduc PL and Price TR: Two-year longitudinal study of poststroke mood disorders:diagnosis and outcome at one and two years. Stroke 18: 837-843, 1987.
29. Simonsick EM, Wallace RB, Blazer DG and Berkman LF: Depressive symptomatology and hypertension-associated morbidity and mortality in older adults. Psychosom Med 57: 427-435, 1995.
30. Vescovi AL, Reynolds BA, Fraser DD and Weiss S: bFGF regulates the proliferative fate of unipotent (neuronal) and bipotent (neuronal/astroglial) EGF-generated CNS progenitor cells. Neuron 11: 951-966, 1993.
31. Lukaszewicz A, Savatier P, Cortay V, et al: Contrasting effects of basic fibroblast growth factor and neurotrophin 3 on cell cycle kinetics of mouse cortical stem cells. J Neurosci 22: 6610-6622, 2002.
32. Lillien L and Raphael H: BMP and FGF regulate the development of EGF-responsive neural progenitor cells. Development 127: 4993-5005, 2000.
33. Ikeda N, Nonoguchi N, Zhao MZ, et al: Bone marrow stromal cells that enhanced fibroblast growth factor-2 secretion by herpes simplex virus vector improve neurological outcome after transient focal cerebral ischemia in rats. Stroke 36: 2725-2730, 2005.
34. Yi ZH, Fang YR and Yu SY: Research progress of gene differential expression of depression brain tissue. Zhongguo Shen Jing Jing Shen Ji Bing Za Zhi 36: 56-59, 2010 (In Chinese).
35. Ay I, Sugimori H and Finkelstein SP: Intravenous basic fibroblast growth factor (bFGF) decreases DNA fragmentation and prevents downregulation of Bcl-2 expression in the ischemic brain following middle cerebral artery occlusion in rats. Brain Res Mol Brain Res 87: 71-80, 2001.
36. Rosenblatt S, Irikura K, Caday CG, et al: Basic fibroblast growth factor dilates rat pial arterioles. J Cereb Blood Flow Metab 14: 70-74, 1994.
37. Longa EZ, Weinstein PR, Carlson S and Cummins R: Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20: 84-91, 1989.
38. Koizumi J, Yoshida Y, Nakazawa T and Ooneda G: Experimental studies of ischemic brain edema: A new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemic area. Jpn J Stroke 16: 1-8, 1986 (In Japanese).
39. Willner P, Towell A, Sampson D, et al: Reduction of sucrose preference by chronic mild unpredictable stress, and its restoration by a tricyclic antidepressant. Psychopharmacology (Berl) 93: 358-364, 1987.
40. Rasul A, El-Nour H, Blakely RD, et al: Effect of chronic mild stress on serotonergic markers in the skin and brain of the NC/Nga atopic-like mouse strain. Arch Dermatol Res 303: 625-633, 2011.
41. Ji YH and Song JG: Relevance among cognition function, autonomic nerve function and the serum levels of monoamine neurotransmitter in patients with post-stroke depression. Lin Chuang Shen Jing Bing Xue Za Zhi 20: 426-428, 2007 (In Chinese).
42. Loubinoux I, Kronenberg G, Endres M, et al: Post-stroke depression: mechanisms, translation and therapy. J Cell Mol Med 16: 1961-1969, 2012.
43. Haneda E, Higuchi M, Maeda J, et al: In vivo mapping of substance P receptors in brains of laboratory animals by high-resolution imaging systems. Synapse 61: 205-215, 2007.
44. Chatterjee K, Fall S and Barer D: Mood after stroke: a case control study of biochemical, neuro-imaging and socio-economic risk factors for major depression in stroke survivors. BMC Neurol 10: 125, 2010.
45. Evans SJ, Choudary PV, Neal CR, et al: Dysregulation of the fibroblast growth factor system in major depression. Proc Natl Acad Sci USA 101: 15506-15511, 2004.